Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-01
2007-05-01
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S159000, C514S313000, C514S314000
Reexamination Certificate
active
10678872
ABSTRACT:
Disclosed herein are compounds represented by Structural Formula (I):(I), wherein the variables are defined herein.Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
REFERENCES:
patent: 5258510 (1993-11-01), Ogawa et al.
patent: 6048873 (2000-04-01), Vasudevan et al.
patent: 6147089 (2000-11-01), DeNinno et al.
patent: 6197786 (2001-03-01), DeNinno et al.
patent: 6291677 (2001-09-01), Vasudevan et al.
patent: 6310075 (2001-10-01), DeNinno et al.
patent: 6313107 (2001-11-01), Vasudevan et al.
patent: 6313142 (2001-11-01), Damon et al.
patent: 6362198 (2002-03-01), Goldstein et al.
patent: 6362199 (2002-03-01), DiFabio
patent: 6395751 (2002-05-01), DeNinno et al.
patent: 6489478 (2002-12-01), DeNinno et al.
patent: 6586448 (2003-07-01), DeNinno et al.
patent: 6600045 (2003-07-01), Damon et al.
patent: 2002/0022218 (2002-02-01), Li et al.
patent: 0987251 (2000-03-01), None
patent: 0992496 (2000-04-01), None
patent: 1125929 (2001-08-01), None
patent: 1221439 (2002-07-01), None
patent: P200253557 (2002-02-01), None
patent: WO 91/05549 (1991-05-01), None
patent: WO 94/01113 (1994-01-01), None
patent: WO 0006153 (2000-02-01), None
patent: WO 0017165 (2000-03-01), None
patent: WO 0017166 (2000-03-01), None
patent: WO 0140190 (2001-06-01), None
patent: WO 0149675 (2001-07-01), None
patent: WO 0158875 (2001-08-01), None
patent: WO 0176629 (2001-10-01), None
patent: WO 0211710 (2002-02-01), None
patent: WO 0218361 (2002-03-01), None
patent: WO 0222585 (2002-03-01), None
patent: WO 02058652 (2002-08-01), None
patent: WO 02079165 (2002-10-01), None
patent: WO 02088069 (2002-11-01), None
patent: WO 03097042 (2003-11-01), None
patent: WO 03097598 (2003-11-01), None
patent: WO 03105849 (2003-12-01), None
patent: WO 2004/035543 (2004-04-01), None
patent: WO04052863 (2004-06-01), None
patent: WO05007094 (2006-12-01), None
Funabashi, CA 72:31075, 1969.
Zalukajevs, CA 48:56687, 1951.
Zalukajevs, CA 62:22149, 1964.
Zalukajevs, CA 59:54789, 1963.
Zalukaev, CA 67:53250, 1967.
Zalukaev, CA 65:81601, 1966.
Carson Kenneth G.
Elder Amy M.
Ghosh Shomir
Harrison Sean
Sprott Kevin
Millennium Pharmaceuticals Inc.
Seaman D. Margaret
LandOfFree
PGD2 receptor antagonists for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PGD2 receptor antagonists for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PGD2 receptor antagonists for the treatment of inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3761105